iTeos Therapeutics, Inc. (ITOS) Tops Q3 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts ITOS Hot Sheet
Join SI Premium – FREE
iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q3 EPS of ($1.05), $0.12 better than the analyst estimate of ($1.17).
For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Starts CVR Partners (UAN) at Hold
- Five Star Bancorp (FSBC) Tops Q3 EPS by 7c
- Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens - 'Weakness a Buying Opportunity'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
